We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mechanism Regulates Organelle Distribution during Cell Division

By LabMedica International staff writers
Posted on 24 Jul 2018
A team of Swiss cell biologists has discovered how cells maintain the integrity and distribution of cytoplasmic organelles during and following the process of cell division.

Previous research has shown that liquid–liquid phase separation underlies the formation and disassembly of organelles that lack membranes in cells, but the cellular mechanisms that control this phenomenon are poorly understood. More...
A prominent example of regulated and reversible segregation of liquid phases may occur during mitosis, when this type of organelles disappear upon nuclear-envelope breakdown and reappear as mitosis is completed.

To better understand this phenomenon, investigators at the University of Zurich (Switzerland) focused their attention on a specific enzyme, the dual-specificity kinase DYRK3 (Dual specificity tyrosine-phosphorylation-regulated kinase 3). This enzyme acts as a central solubilizing agent for several types of membraneless organelles during mitosis.

The investigators reported in the July 4, 2018, issue of the journal Nature that DYRK3 kinase activity was essential to prevent the unmixing of the mitotic cytoplasm into aberrant liquid-like hybrid organelles and the over-nucleation of spindle bodies. DYRK3 promoted the mixing of the liquid phases within the cytoplasm to ensure correct separation of chromosomes and uniform division of the cell's components. Following cell division, the enzyme was denatured and individual phases were reestablished. Failure of the phase separation mechanism to function correctly could result in incomplete chromosome separation and incorrect distribution to the daughter cells, which is a common characteristic of numerous cancers.

"These fundamental findings give us completely new insights into cell division: as a process in which the cell contents mix together and then separate again," said senior author Dr. Lucas Pelkmans, professor of molecular life sciences at the University of Zurich. "Thanks to the discovery as to which proteins control phase separation, new strategies can be pursued to prevent mistakes in this process."

Related Links:
University of Zurich


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.